Please assess the completion status of the following clinical trial:

Trial Title: Low Dose Cyclosporin A in Primary Sjögren Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of a primary Sjögren´s Syndrome~* Liver values above 1,5 ULN~* uncontrolled arterial hypertension~* intraarticular or systemic use of Glucocorticoids in the last 4 weeks before~* begin with Study medication~Exclusion Criteria:~* pre-treatment with Cyclosporine A~* Infection~* Neoplasia~* relevant cardiac, pulmonary, neurologic or psychiatric disease~* life-Vaccination within 4 weeks before begin with study medication~* pregnant or breast-feeding~* weight under 45kg or more than 110kg

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Cyclosporine A (Type: OTHER): All patients will receive Cyclosporine A in a dose of 2mg/kg/BW daily for 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).